ArticleFrontiers in cardiovascular medicine2025
Case Report: Application of the AngioJet thrombectomy system in acute lower extremity deep vein thrombosis complicated by transplanted renal vein thrombosis (report of two cases).
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lower extremity deep venous thrombosis (DVT) combined with transplanted renal vein thrombosis represents a rare and complex form of venous thromboembolism that leads to obstruction of the transplanted renal vein. This condition results in parenchymal edema of the kidney, ultimately impairing the function of the transplanted organ. It constitutes a catastrophic complication following renal transplantation, potentially resulting in loss of function of the transplanted kidney and failure of the surgical procedure. The primary objective of treatment is to promptly remove thrombi from the transplanted renal vein, thereby restoring normal venous return and renal function as swiftly as possible to enhance patient prognosis. Currently, surgical thrombectomy and thrombolytic therapy are considered the mainstay treatment modalities. Surgical thrombectomy is generally recommended as a first-line approach due to its efficacy in achieving rapid thrombus removal. To date, there exists limited literature regarding the utilization of the AngioJet thrombectomy system for managing DVT in conjunction with transplanted renal vein thrombosis. In this report, we present two cases involving middle-aged male patients diagnosed with acute lower extremity DVT complicated by transplanted renal vein thrombosis. Both patients had undergone allogeneic kidney transplantation 15 and 4 years prior, respectively. In these instances, we employed the AngioJet thrombectomy system for emergency thrombus aspiration treatment. The thrombi within both patients' lower extremity deep veins and their respective transplanted renal veins were completely removed. Subsequently, urine output gradually increased for both patients; moreover, their renal function progressively improved to an acceptable range. Notably, neither patient developed postoperative complications nor exhibited any recurrence of thrombi during follow-up evaluations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.